The Second XIANGYA Hospital Of Central South University | China
Author Profile:
Scopus
🌟 BIOGRAPHY OF MS. ZHIQI ZHAO: A RISING STAR IN RESPIRATORY MEDICINE AND CLINICAL RESEARCH
🎓 EARLY ACADEMIC PURSUITS
Ms. Zhiqi Zhao began her academic journey in medicine at the Xiangya School of Medicine, Central South University, where she was enrolled in the prestigious 8-year Clinical Medicine Program from September 2016 to June 2022. Throughout her undergraduate years, she distinguished herself through her academic excellence and research enthusiasm. She was awarded the Central South University Xinmiao Award and successfully led a National College Student Innovation and Entrepreneurship Project, while participating in two other innovation projects (one national, one university-level).
Her early clinical exposure came through clerkships in internal medicine, surgery, gynecology, and pediatrics, conducted at the renowned Xiangya Second Hospital. This period laid a strong foundation for her future medical and research endeavors.
🏥 PROFESSIONAL ENDEAVORS
Currently, Ms. Zhao is a Ph.D. Candidate in Pulmonary and Critical Care Medicine at Xiangya Hospital Second Affiliated to Central South University, a role she has held since September 2022. Her GPA of 3.70/4.0 reflects her dedication and aptitude in a highly demanding field.
She has successfully completed rigorous clinical rotations across departments including internal medicine, surgery, gynecology, pediatrics, diagnostics, and other key support specialties. In addition, she has passed both the Practical and Written Physician Qualification Exams in China (2023), demonstrating her readiness for professional clinical responsibilities.
🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON ECHOCARDIOGRAM
Ms. Zhao’s research career is marked by significant contributions to chronic respiratory diseases, especially Chronic Obstructive Pulmonary Disease (COPD) and asthma, and the impact of corticosteroids and tobacco exposure on disease outcomes.
Her Ph.D. research includes a pivotal role in the Hunan Natural Science Foundation project titled:
🔬 "Mechanism by which Early-Life Tobacco Exposure Contributes to COPD via AQP1 Methylation Inhibiting HIF-2α / VEGF-A / RA Signaling Pathway" (Project No. 2023JJ30742), under the leadership of PI Dr. Huihui Zeng.
She has also participated in poster presentations such as the 21st National Conference on Clinical Epidemiology and Evidence-Based Medicine, where her work on corticosteroid impact on COPD mortality gained recognition.
📄 IMPACT AND INFLUENCE THROUGH PUBLICATIONS
Ms. Zhao is a co-author of several high-impact journal publications, including:
-
Redox Biology (IF = 11.40, JCR Q1): Research on TET2 deficiency and ferroptosis in COPD.
-
Journal of General Internal Medicine (IF = 5.70, JCR Q1): Focused on inhaled medication adherence in Chinese COPD patients.
-
Frontiers in Medicine (IF = 5.09, JCR Q2): Comparing asthma and COPD patient responses during the COVID-19 pandemic.
-
Scientific Reports (IF = 4.60, JCR Q2): AECOPD treatment efficacy with Nemonoxacin vs. Moxifloxacin.
These contributions not only underscore her expertise but also highlight her commitment to evidence-based medicine and improving patient outcomes.
🧠 ACADEMIC CITES AND SCHOLARSHIP
Ms. Zhao has been consistently recognized for her academic achievements, including:
🏅 Graduate Academic Scholarship (Second Prize – twice, Third Prize – once)
📌 Presenter at a national academic conference
📚 Contributor to studies currently under peer review, indicating ongoing research momentum
Her published works are cited in high-tier journals, reflecting scholarly impact in respiratory and internal medicine communities.
💻 TECHNICAL PROFICIENCIES
Ms. Zhao is adept in a wide array of research and analytical tools, including:
-
Statistical & Bioinformatics Tools: R, SPSS, FlowJo, GraphPad Prism, ImageJ
-
Document & Reference Management: EndNote, Adobe Acrobat
-
Media & Communication Tools: Photoshop, Premiere
-
Daily Office Work: Word, Excel, PowerPoint
These proficiencies allow her to manage and analyze complex clinical data efficiently and to present her findings in impactful ways.
💬 LANGUAGE & COMMUNICATION
📘 English Proficiency: Passed CET-6
Her ability to communicate scientific findings effectively in both Chinese and English enhances her global research collaboration potential.
💫 LEGACY AND FUTURE CONTRIBUTIONS
Ms. Zhao stands out not only for her current achievements but also for her vision and adaptability. She brings a unique blend of clinical insight, research acumen, and passion for discovery. With her expanding portfolio of published work, active participation in national-level projects, and a strong academic background, she is poised to make transformative contributions to pulmonary medicine and global respiratory health.
Her legacy, even in these early years, is that of a committed scholar-practitioner bridging research and real-world impact, and her future undoubtedly holds promise in both academic medicine and clinical innovation.
📑NOTABLE PUBLICATIONS
"Early smoking lead to worse prognosis of COPD patients: a real world study"
Authors: Wu, J., Meng, W., Ma, Y., Zhao, Z., Xiong, R., Wang, J., Zhao, R., Zeng, H., Chen, Y.
Journal: Respiratory Research
Year: 2024
"Suboptimal peak inspiratory flow rate: a noticeable risk factor for inhaler concordance in patients with chronic airway diseases"
Authors: Meng, W., Xiong, R., Zhao, Z., Zeng, H., Chen, Y.
Journal: BMJ Open Respiratory Research
Year: 2024